Displaying items by tag: division of cardiovascular disease

The UA System Board of Trustees awarded the rank of Professor Emeritus to Craig Beard, Etty “Tika” Benveniste, Louis Dell’Italia, Robert F. Pass, John Hablitz and Clark Douglas Witherspoon and the rank of Endowed Professor to Jeff Holmes during its June 3-4 meeting.

This year, the university recognizes 50 years of service by Jeanne Hutchison, Ph.D., and Ferdinand Urthaler, M.D., and 45 years of service by Robert Kim M.D., and Joseph Lovetto. In addition, 294 employees with 20 or more years and 904 with five, 10 and 15 years will honored for their longevity.

This year, the new President’s Award for Excellence in Shared Values honors Blazers who demonstrated one or more of UAB’s shared values in the course of their work during the extraordinary times presented by the COVID-19 pandemic.

A novel detergent-like compound developed by UAB researchers that blocks HIV and HSV viruses from entering cells could have the same effect against the virus that causes COVID-19. The team is exploring the compound’s potential with a commercialization grant from the U.S. Economic Development Administration.

A bioluminescent one-two punch targets mitochondria in cancer cells and evades the blood-brain barrier for a potential new treatment for neuroendocrine cancers, triple-negative breast cancer and brain cancers.

Lab-grown human heart tissue could mean better drug tests, faster transplants and more accurate models of disease. To get there, Palaniappan Sethu, Ph.D., is stretching ingenuity.

In a talk at UAB on March 6, the NIH director shared his thoughts on exceptional opportunities for science and young scientists — and highlighted several exciting UAB projects.

Learn how UAB researchers are taking on the most feared complication of the new generation of blood-thinning drugs. 

Pay-to-publish journals are often outright scams and undermine the foundation of legitimate research, says Arline Savage, Ph.D. Here’s how faculty and their departments can defend themselves.